1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 9th September 2024 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

Epidemics (including Covid-19, not Long Covid)

Discussion of epidemics including Covid-19

Page 6 of 27
Sort By:
Title Start Date
Replies Views
Last Message ↓
  1. Sly Saint

    A brief overview of SARS-CoV-2 infection and its management strategies: a recent update 2023, Das et al

    Sly Saint, Sep 25, 2023
    Replies:
    2
    Views:
    389
    rvallee
    Sep 25, 2023
  2. Dakota15

    USA - NIH: Clinical trial to test immune modulation strategy for hospitalized covid-19 patients begins, Sept 2023

    Dakota15, Sep 24, 2023
    Replies:
    0
    Views:
    360
    Dakota15
    Sep 24, 2023
  3. Mij

    TMPRSS2 activation of Omicron lineage Spike glycoproteins is regulated by TMPRSS2 cleavage of ACE2, 2023, Anupriya Aggarwal et al

    Mij, Sep 23, 2023
    Replies:
    1
    Views:
    402
    Mij
    Sep 23, 2023
  4. SNT Gatchaman

    [Preprint] Identification of a Druggable Site on GRP78 at the GRP78-SARS-CoV-2 Interface and Compounds to Disrupt that Interface, 2023, Lazou et al.

    SNT Gatchaman, Sep 15, 2023
    Replies:
    0
    Views:
    465
    SNT Gatchaman
    Sep 15, 2023
  5. EndME

    Identification of new drugs to counteract anti-spike IgG-induced hyperinflammation in severe COVID-19, 2023, Geyer et al

    EndME, Sep 13, 2023
    Replies:
    1
    Views:
    480
    EndME
    Sep 13, 2023
  6. EndME

    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19, 2023, Cakir

    EndME, Sep 12, 2023
    Replies:
    1
    Views:
    397
    rvallee
    Sep 12, 2023
  7. Mij

    Two coronaviruses isolated from central nervous system tissue of two multiple sclerosis patients

    Mij, Sep 12, 2023
    Replies:
    4
    Views:
    426
    duncan
    Sep 12, 2023
  8. Mij

    Molecular mechanisms of SARS-CoV-2 resistance to nirmatrelvir, 2023, Yinkai Duan et al

    Mij, Sep 11, 2023
    Replies:
    0
    Views:
    364
    Mij
    Sep 11, 2023
  9. Mij

    A 53-year-old Californian man, Armando Ramos, Was Hospitalized Due to Unforeseen Sickness While Traveling to the Philippines

    Mij, Sep 9, 2023
    Replies:
    2
    Views:
    678
    Ash
    Sep 11, 2023
  10. EndME

    SARS-CoV-2 Viral Clearance and Evolution Varies by Extent of Immunodeficiency, 2023, Li et al

    EndME, Sep 11, 2023
    Replies:
    0
    Views:
    355
    EndME
    Sep 11, 2023
  11. SNT Gatchaman

    [Preprint] Quantity of SARS-CoV-2 RNA copies exhaled per minute during natural breathing over the course of COVID-19 infection, 2023, Lane et al.

    SNT Gatchaman, Sep 9, 2023
    Replies:
    0
    Views:
    425
    SNT Gatchaman
    Sep 9, 2023
  12. EndME

    Dissecting human population variation in single-cell responses to SARS-CoV-2, 2023, Quintana-Murci et al

    EndME, Aug 31, 2023
    Replies:
    0
    Views:
    360
    EndME
    Aug 31, 2023
  13. ahimsa

    Forbes: Public Pushes Back On CDC’s Plan To Weaken Infection Control

    ahimsa, Aug 27, 2023
    Replies:
    5
    Views:
    590
    rvallee
    Aug 28, 2023
  14. SNT Gatchaman

    New Zealand's COVID-19 elimination strategy and mortality patterns, 2023, Kung et al.

    SNT Gatchaman, Aug 27, 2023
    Replies:
    0
    Views:
    453
    SNT Gatchaman
    Aug 27, 2023
  15. Andy

    Plasma miR-195-5p predicts the severity of Covid-19 in hospitalized patients 2023 Moatar et al

    Andy, Aug 24, 2023
    Replies:
    0
    Views:
    371
    Andy
    Aug 24, 2023
  16. ahimsa

    CTV News: Prior Omicron infection didn't protect some seniors from reinfection: study

    ahimsa, Aug 23, 2023
    Replies:
    3
    Views:
    497
    Ash
    Aug 23, 2023
  17. SNT Gatchaman

    Transcriptional reprogramming from innate immune functions to a pro-thrombotic signature by monocytes in COVID-19, 2022, Maher et al

    SNT Gatchaman, Dec 27, 2022
    Replies:
    4
    Views:
    1,101
    SNT Gatchaman
    Aug 21, 2023
  18. EndME

    SARS-CoV-2-specific T cell therapy for severe COVID-19: a randomized phase 1/2 trial, 2023, Yannaki et al

    EndME, Aug 19, 2023
    Replies:
    0
    Views:
    512
    EndME
    Aug 19, 2023
  19. SNT Gatchaman

    Class switch towards non-inflammatory, spike-specific IgG4 antibodies after repeated SARS-CoV-2 mRNA vaccination, 2022, Irrgang et al

    SNT Gatchaman, Dec 27, 2022
    Replies:
    3
    Views:
    1,001
    SNT Gatchaman
    Aug 14, 2023
  20. EndME

    Differential effects of SARS-CoV-2 variants on central nervous system cells and blood–brain barrier functions, 2023, Proust et al

    EndME, Aug 5, 2023
    Replies:
    2
    Views:
    1,098
    SNT Gatchaman
    Aug 13, 2023
Showing threads 101 to 120 of 530

Thread Display Options

Loading...
Page 6 of 27